Antisense knockdown of PKC-alpha using LNA-oligos. 2003

Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
Cureon A/S, Copenhagen, Denmark. bh@cureon.com

Full-length and 4 nucleotides truncated Locked Nucleic Acid (LNA) modifications of ISIS 3521 were compared for antisense properties in a cellular assay. ISIS 3521 is a 20-mer phosphorothioate designed to hybridise to human protein kinase C-alpha (PKC-alpha) mRNA and is currently submitted to clinical trials against cancer. We report that LNA can potentate this antisense oligo and retain the antisense potential with shorter oligos.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013873 Thionucleotides Nucleotides in which the base moiety is substituted with one or more sulfur atoms.
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic
D016376 Oligonucleotides, Antisense Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize. Anti-Sense Oligonucleotide,Antisense Oligonucleotide,Antisense Oligonucleotides,Anti-Sense Oligonucleotides,Anti Sense Oligonucleotide,Anti Sense Oligonucleotides,Oligonucleotide, Anti-Sense,Oligonucleotide, Antisense,Oligonucleotides, Anti-Sense

Related Publications

Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
January 2023, Nucleic acid therapeutics,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
January 2005, Oncology research,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
June 2014, Nucleic acid therapeutics,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
November 2010, Rinsho shinkeigaku = Clinical neurology,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
September 2016, Analytical biochemistry,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
March 2002, Developmental biology,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
June 2021, Cancer discovery,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
February 2010, Bioconjugate chemistry,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
October 1999, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Jens Bo Hansen, and Majken Westergaard, and Charlotte Albaek Thrue, and Birgit Giwercman, and Henrik Oerum
January 2017, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!